{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:31:33Z","timestamp":1781008293191,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.bulcan.2020.09.010","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T18:53:46Z","timestamp":1604948026000},"page":"1274-1283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres"],"prefix":"10.1016","volume":"107","author":[{"given":"Xavier","family":"Carle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauris","family":"Gastaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Salleron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali Pascale","family":"Tardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Caujolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Thyss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Thariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bulcan.2020.09.010_bib0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.seminoncol.2010.03.014","article-title":"Locoregional management of hepatic metastasis from primary uveal melanoma","volume":"37","author":"Sato","year":"2010","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2020.09.010_bib0130","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00270-017-1588-2","article-title":"Percutaneous isolated hepatic perfusion as a treatment for isolated hepatic metastases of uveal melanoma: patient outcome and safety in a multi-centre study","volume":"40","author":"Vogl","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.010_bib0135","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejso.2009.08.010","article-title":"Preoperative staging of liver metastases from uveal melanoma by magnetic resonance imaging (MRI) and fluorodeoxyglucose-positron emission tomography (FDG-PET)","volume":"36","author":"Servois","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.010_bib0140","first-page":"131","article-title":"Intra-arterial hepatic chemoembolization (TACE) of liver metastases from ocular melanoma with slow-release irinotecan-eluting beads. Early results of a phase II clinical study","volume":"23","author":"Fiorentini","year":"2009","journal-title":"In Vivo"},{"issue":"6","key":"10.1016\/j.bulcan.2020.09.010_bib0145","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00270-015-1093-4","article-title":"Transarterial chemoembolization of liver metastases from uveal melanoma using irinotecan-loaded beads: treatment response and complications","volume":"38","author":"Carling","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.010_bib0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0033-1333652","article-title":"Transhepatic therapies for metastatic uveal melanoma","volume":"30","author":"Eschelman","year":"2013","journal-title":"Semin Intervent Radiol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.010_bib0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2020.09.010_bib0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"(mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.010_bib0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","article-title":"Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver","volume":"35","author":"Bruix","year":"2001","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.010_bib0170","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.ejrad.2009.03.064","article-title":"Transarterial chemoembolization of liver metastases in patients with uveal melanoma","volume":"74","author":"Huppert","year":"2010","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.010_bib0175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/CMR.0000000000000129","article-title":"A retrospective analysis of 141 patients with liver metastases from uveal melanoma: a two-cohort study comparing transarterial chemoembolization with CPT-11 charged microbeads and historical treatments","volume":"25","author":"Valpione","year":"2015","journal-title":"Melanoma Res"},{"issue":"6","key":"10.1016\/j.bulcan.2020.09.010_bib0180","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2214\/AJR.11.7748","article-title":"Fotemustine chemoembolization of hepatic metastases from uveal melanoma: a retrospective single-center analysis","volume":"199","author":"Edelhauser","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.010_bib0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00432-006-0155-z","article-title":"Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival","volume":"133","author":"Vogl","year":"2007","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.010_bib0190","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10147-017-1095-0","article-title":"Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population","volume":"22","author":"Shibayama","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.010_bib0195","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jvir.2014.11.037","article-title":"Double-blinded, randomized phase II study using embolization with or without granulocyte-macrophage colony-stimulating factor in uveal melanoma with hepatic metastases","volume":"26","author":"Valsecchi","year":"2015","journal-title":"J Vasc Interv Radiol"},{"issue":"12","key":"10.1016\/j.bulcan.2020.09.010_bib0200","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1055\/s-0031-1281743","article-title":"Transarterial hepatic chemoperfusion of uveal melanoma metastases: survival and response to treatment","volume":"183","author":"Heusner","year":"2011","journal-title":"Rofo"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.010_bib0205","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1245\/s10434-015-4982-5","article-title":"Long-term follow-up evaluation of 68 patients with uveal melanoma liver metastases treated with isolated hepatic perfusion","volume":"23","author":"Ben-Shabat","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2020.09.010_bib0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1245\/s10434-013-3304-z","article-title":"Isolated hepatic perfusion for ocular melanoma metastasis: registry data suggests a survival benefit","volume":"21","author":"Olofsson","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2020.09.010_bib0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejso.2008.07.004","article-title":"Isolated hypoxic hepatic perfusion with melphalan in patients with irresectable ocular melanoma metastases","volume":"35","author":"van Etten","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.010_bib0220","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1245\/s10434-015-4968-3","article-title":"Results of a randomized controlled multicenter phase III trial of percutaneous hepatic perfusion compared with best available care for patients with melanoma liver metastases","volume":"23","author":"Hughes","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2020.09.010_bib0225","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.ophtha.2004.06.022","article-title":"Geographic disparities in diagnostic screening for metastatic uveal melanoma","volume":"111","author":"Gombos","year":"2004","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.bulcan.2020.09.010_bib0230","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008390-200508000-00011","article-title":"Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study","volume":"15","author":"Patel","year":"2005","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.bulcan.2020.09.010_bib0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e328334c36e","article-title":"Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome","volume":"20","author":"Schuster","year":"2010","journal-title":"Melanoma Res"},{"issue":"5","key":"10.1016\/j.bulcan.2020.09.010_bib0240","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00270-011-0287-7","article-title":"Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations","volume":"35","author":"Lencioni","year":"2012","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455120304082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:33:25Z","timestamp":1757792005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455120304082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0007455120304082"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.09.010","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2020.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}